UniPharma Co., Ltd. (TPEX:6621)
Taiwan
· Delayed Price · Currency is TWD 12.45
0.00 (0.00%)
Mar 10, 2026, 1:55 PM CST
UniPharma Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 46.12 | 58.68 | 68.64 | 63.76 | 75.96 | 74.59 | Upgrade
|
| Short-Term Investments | 98.5 | 98.5 | 98.5 | 98.5 | 99.5 | 113.5 | Upgrade
|
| Cash & Short-Term Investments | 144.62 | 157.18 | 167.14 | 162.26 | 175.46 | 188.09 | Upgrade
|
| Cash Growth | 5.01% | -5.96% | 3.01% | -7.52% | -6.72% | -6.18% | Upgrade
|
| Accounts Receivable | 15.79 | 16.72 | 21.07 | 34.1 | 22.68 | 24.17 | Upgrade
|
| Other Receivables | 0.25 | 0.13 | 0.18 | 0 | 0.3 | 0.44 | Upgrade
|
| Receivables | 16.04 | 16.86 | 21.25 | 34.11 | 22.98 | 24.6 | Upgrade
|
| Inventory | 27.75 | 22.27 | 28.94 | 31.05 | 35.94 | 25.66 | Upgrade
|
| Prepaid Expenses | - | - | 0.06 | 0.32 | - | - | Upgrade
|
| Other Current Assets | 4.99 | 3.71 | 8.83 | 10.56 | 27.01 | 3.1 | Upgrade
|
| Total Current Assets | 193.4 | 200.01 | 226.23 | 238.28 | 261.39 | 241.45 | Upgrade
|
| Property, Plant & Equipment | 21.11 | 23.79 | 11.57 | 8.73 | 13.46 | 46.89 | Upgrade
|
| Long-Term Investments | 66.56 | 94.3 | 101.26 | 73.58 | 59.09 | 77.64 | Upgrade
|
| Other Intangible Assets | 3.3 | 3.58 | 1.94 | 2.22 | 2.53 | 36.58 | Upgrade
|
| Other Long-Term Assets | 7.25 | 7.3 | 9.07 | 9.77 | 11.71 | 13.01 | Upgrade
|
| Total Assets | 291.61 | 328.98 | 350.07 | 332.57 | 348.18 | 415.57 | Upgrade
|
| Accounts Payable | 14.01 | 14.49 | 22.25 | 6.09 | 27.66 | 2.22 | Upgrade
|
| Accrued Expenses | - | - | - | 0.59 | - | - | Upgrade
|
| Current Portion of Leases | 3.69 | 3.71 | 0.27 | 3.26 | 3.46 | 5.67 | Upgrade
|
| Current Unearned Revenue | 2.41 | 2.57 | 2.72 | 3.12 | 2.41 | 2.55 | Upgrade
|
| Other Current Liabilities | 11.15 | 12.39 | 11.87 | 15.71 | 13.27 | 14.72 | Upgrade
|
| Total Current Liabilities | 31.25 | 33.15 | 37.12 | 28.78 | 46.8 | 25.15 | Upgrade
|
| Long-Term Leases | 9.12 | 11.07 | - | 0.27 | 3.53 | 11.16 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.29 | 0.29 | 0.29 | 0.29 | Upgrade
|
| Total Liabilities | 40.37 | 44.22 | 37.4 | 29.33 | 50.61 | 36.59 | Upgrade
|
| Common Stock | 355.01 | 355.01 | 355.01 | 355.01 | 355.01 | 355.01 | Upgrade
|
| Additional Paid-In Capital | 0.38 | 0.38 | 0.38 | 0.38 | 17.94 | 69.91 | Upgrade
|
| Retained Earnings | -111.88 | -88.93 | -60.92 | -40.34 | -51.39 | -36.44 | Upgrade
|
| Treasury Stock | - | - | - | - | -3.91 | -3.91 | Upgrade
|
| Comprehensive Income & Other | 7.74 | 18.29 | 18.2 | -11.8 | -20.08 | -5.6 | Upgrade
|
| Shareholders' Equity | 251.24 | 284.75 | 312.67 | 303.24 | 297.57 | 378.98 | Upgrade
|
| Total Liabilities & Equity | 291.61 | 328.98 | 350.07 | 332.57 | 348.18 | 415.57 | Upgrade
|
| Total Debt | 12.8 | 14.78 | 0.27 | 3.53 | 6.99 | 16.82 | Upgrade
|
| Net Cash (Debt) | 131.82 | 142.4 | 166.87 | 158.73 | 168.46 | 171.26 | Upgrade
|
| Net Cash Growth | 8.85% | -14.67% | 5.13% | -5.78% | -1.63% | -3.80% | Upgrade
|
| Net Cash Per Share | 3.71 | 4.01 | 4.70 | 4.47 | 4.79 | 4.87 | Upgrade
|
| Filing Date Shares Outstanding | 35.5 | 35.5 | 35.5 | 35.5 | 35.2 | 35.2 | Upgrade
|
| Total Common Shares Outstanding | 35.5 | 35.5 | 35.5 | 35.5 | 35.2 | 35.2 | Upgrade
|
| Working Capital | 162.15 | 166.86 | 189.11 | 209.51 | 214.59 | 216.3 | Upgrade
|
| Book Value Per Share | 7.08 | 8.02 | 8.81 | 8.54 | 8.45 | 10.77 | Upgrade
|
| Tangible Book Value | 247.94 | 281.17 | 310.73 | 301.03 | 295.04 | 342.4 | Upgrade
|
| Tangible Book Value Per Share | 6.98 | 7.92 | 8.75 | 8.48 | 8.38 | 9.73 | Upgrade
|
| Machinery | 29.2 | 28.62 | 28.14 | 20.03 | 19.88 | 46.88 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 0.38 | 5.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.